Provention Bionow A Wholly Owned Subsidiary Of Sanofiis A Biopharmaceutical Company Dedicated To Intercepting And Preventing Immune Mediated Diseasesfollowing Its Acquisition By Sanofi On April 272023Provention Bio S Flagship Producttzieldteplizumab Mzwv Is Part Of Sanofiae S General Medicines Portfoliotzield Is A First In Class Anti Cd3 Monoclonal Antibody Approved By The Fda To Delay The Onset Of Stage 3 Type 1 Diabetes In Patients With Stage 2 Disease The Company Focuses On Therapies For Autoimmune And Inflammatory Diseaseswith Its Operations Now Integrated Into Sanofiae S Broader Research And Development Strategyprovention Bio S Legacy Includes Partnerships For Clinical Development And Commercializationnotably A Co Promotion Agreement With Sanofi Us For The Launch Of Tzieldthis Integration Enhances Sanofiae S Capabilities In Addressing High Unmet Medical Needs In Immune Mediated Diseases
No conferences found for this company.
| Company Name | Sanofi Saglik Urunleri Ltd Sti |
| Country |
Turkey
|
| Address | N/A |
| Telephone | N/A |
| N/A |
